Summary
Administration ofα-difluoromethylornithine (DFMO) to mice was found to inhibit both the cutaneous carcinogenesis and the immunosuppression induced by ultraviolet B (UVB) irradiation. BALB/cAnNTacfBR mice were given 1% F2MeOrn in their drinking water throughout the experiment. After 3 weeks, mice received UVB irradiation consisting of five 30-min exposures per week to banks of six FS40 Westinghouse sunlamps. In the photocarcinogenesis study, mice received a total dose of approximately 1273 kJ m−2. Skin cancer incidence in UV-irradiated mice was 38% 28 weeks after the first UV exposure; DFMO reduced this incidence to 9% (P= 0.025, log-rank test). Although DFMO has been demonstrated to be chemopreventive of chemical carcinogenesis, this is the first report that it is effective against cancers induced by a physical carcinogen. The immunosuppression induced by UVB irradiation prevents the host from rejecting antigenic, syngeneic UV-induced tumors, which normal mice can reject. The level of immunosuppression in UV-irradiated mice treated with DFMO was measured by a passive-transfer assay. Splenocytes from UV-irradiated mice to naive mice prevented the recipients from rejecting 20/24 UV-induced tumor challenges, whereas splenocytes from UV-irradiated mice treated with DFMO did not prevent recipients from rejecting such challenges (2/24 grew). The difference between these values was significant (P<0.001, two-sample test for binomial proportions). Phenotypic analysis of splenocytes used in the passive transfer, using a biotin-avidin-immunoperoxidase technique, revealed that DFMO treatment prevented the reduction of Ia expression normally seen in UV-irradiated mice. Thus, administration of DFMO reduced skin carcinogenesis and immunosuppression induced by UVB irradiation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IL-1, -2 etc.:
-
interleukin-1, -2 et
- DFMO:
-
α-difluoromethylornithine
References
Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoerdsma A (1986) Phase II trials of α-difluoromethylornithinean inhibitor of polyamine biosynthesis. Cancer Treat Rep 70:843–5
Balkwill FR (1989) Cytokines in cancer therapy. Oxford University Press, Oxford
Bowlin TL, McKown BJ, Sunkara PS (1986) Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines. Cell Immunol 98:341–350
Bowlin TL, McKown BJ, Babcock G, Sunkara PS (1987) Intracellular polyamine biosynthesis is required for interleukin-2 responsiveness during lymphocyte mitogenesis. Cell Immunol 106:420–427
Bowlin TL, Hoeper BJ, Rosenberger AL, Davis GF, Sunkara PS (1990) Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice. Cancer Res 50:4510–4514
Croghan MK, Booth A, Meyskens FL Jr (1988) A phase I trial of recombinant interferon-α and α-difluoromethylornithine in metastatic melanoma. J Biol Response Mod 7:409–415
DeLellis RA, Sternberger LA, Mann RB, Banks PM, Nakane PK (1979) Immunoperoxidase techniques in diagnostic pathology. Am J Clin Pathol 71:483–488
DiGiovanni J, Kruszewski FH, Chenicek KJ (1988) Modulation of chrysarobin skin tumor promotion. Carcinogenesis 9:1445–1450
Dye ES, North RJ (1981) T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases. J Exp Med 154:1033–1042
Endo Y, Matsushima K, Onozaki K, Oppenheim JJ (1988) Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor. J Immunol 141:2342–8
Farrar WL, Vinocour M, Cleveland JL, Harel-Bellan A (1988) Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP. J Immunol 141:967–971
Fears TR, Scotto J (1982) Changes in skin cancer morbidity between 1971–1972 and 1977–1978. J Natl Cancer Inst 69:365–370
Flescher E, Bowlin T, Ballester A, Houk R, Talal N (1989) Increased polyamines may down-regulate interleukin-2 production in rheumatoid arthritis. J Clin Invest 83:1356–1362
Gensler HL (1988) Enhancement of chemical carcinogenesis in mice by systemic effects of ultraviolet irradiation. Cancer Res 48:620–623
Gensler HL (1989) Reduction of immunosuppression in UV-irradiated mice by dietary retinyl palmitate plus canthaxanthin. Carcinogenesis 10:203–207
Greene MI, Sy MS, Kripke M (1979) Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci USA 76:6591–6595
Grogan TM, Jolley MT, Rangel HT (1983) Immunoarchitecture of the human spleen. Lymphology 16:72–82
Hoon DS, Bowker RJ, Cochran AJ (1987) Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res 47:1529–1533
Hsu S-M, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577–580
Kingsnorth AN, King WW, Diekema KA, McCann PP, Ross JS, Malt RA (1983) Inhibition of ornithine decarboxylase with α-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res 43:2245–2249
Klinken SP, Holmes KL, Morse HC III, Thorgeirsson SS (1988) Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO. Exp Cell Res 178:185–198
Mihm S, Risso A, Stohr M, Oberdorfer F, Droge W (1989) Down-regulation of T cell growth factor production by ornithine decarboxylase and its product putrescine: DL-α-difluoromethylornithine suppresses general protein synthesis but augments simultaneously the production of interleukin-2. Exp Cell Res 180:383–398
Mukherji B, Guha A, Loomis R, Ergin MT (1987) Cell-mediated amplification and down-regulation of cytotoxic immune response against autologous human cancer. J Immunol 138:1987–1991
Mullen SA, Urban JL, Van Waes C, Rowley DA, Schreiber H (1985) Multiple cancers. Tumor burden permits the outgrowth of other cancers. J Exp Med 162:1665–1682
North RJ, Bursuker I (1984) Generation and decay of the immune response to a progressive fibrosarcoma: I.Ly-1+2− suppressor T cells down-regulate the generation of Ly-1−2+ effector T cells. J Exp Med 159:1295–1311
Pegg AE (1986) Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234:249–262
Pegg AE, McCann PP (1982) Polyamine metabolism and function. Am J Physiol 243:C212-C221.104
Reed JC (1987) Protooncogene expression in lymphoid cells: implication for the regulation of normal cellular growth. In: Greene MI, Hamaoka T (eds) Development and recognition of the transformed cell. Plenum, New York, pp 39–49
Roberts LK, Daynes RA (1980) Modification of the immunogenic properties of chemically induced tumors arising in hosts treated concomitantly with ultraviolet light. J Immunol 125:438–447
Scotto J, Fears TR, Fraumeni JF Jr (1983) Incidence of nonmelanoma skin cancer in the United States. NIH Publication no. 83:2433
Sharkis SJ, Luk GD, Collector MI, McCann PP, Baylin SB, Sensenbrenner LL (1983) Regulation of hematopoiesis:II. The role of polyamine inhibition on helper or suppressor influences of the thymus. Blood 61:604–7
Snyder RD, Sunkara PS (1990) Effect of polyamine depletion on DNA damage and repair following UV irradiation of HeLa cells. Photochem Photobiol 52:525–532
Takigawa M, Enomoto M, Nishida Y, Pan HO, Kinoshita A, Suzuki F (1990) Tumor angiogenesis and polyamines: α-difluoromethylomithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro. Cancer Res 50:4131–4138
Thompson HJ, Meeker LD, Herbst EJ, Ronan AM, Minocha R (1985) Effect of concentration of DL-2-difluoromethylornithine on murine mammary carcinogenesis. Cancer Res 45:1170–1173
Uchida K, Seidenfeld J, Rademaker A, Oyasu R (1989) Inhibitory action of α-difluoromethylornithine onN-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis. Cancer Res 49:5249–5253
Verma AK, Duvick L, Ali M (1986) Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and α-difluoromethylornithine. Carcinogenesis 7:1019–1023
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gensler, H.L. Prevention byα-difluoromethylornithine of skin carcinogenesis and immunosuppression induced by ultraviolet irradiation. J Cancer Res Clin Oncol 117, 345–350 (1991). https://doi.org/10.1007/BF01630718
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01630718